General Information

Stock Quote

ABMD (Common Stock)
Exchange NASDAQ (US Dollar)
Price   $92.78
Change (%)   Stock is Down  3.12  (3.25%)
Volume   649,100
Data as of 09/01/15 4:00 PM ET
Minimum 20 minute delay
Refresh quote

Corporate Profile

Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

Abiomed CEO, Chairman, and President, Michael R. Minogue, has focused the company’s efforts on developing ground-breaking technologies designed to assist or replace the life-sustaining pumping function of the failing heart. The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.


More »   Recent News

Date Title  

DANVERS, Mass. (August 17, 2015) - Abiomed, Inc.(Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, announced today that it has submitted U.S Food & Drug Administration (FDA) pre-market approval (PMA) supplemental submissions requesting to expand Impella® 2.5 PMA approval to all of the Impella fam...


DANVERS, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ...


DANVERS, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- ...


DANVERS, Mass., Aug. 05, 2015 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD) announced today that the Company will webcast presentations at its Investor ...


DANVERS, Mass. - August 4, 2015 - Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2016 revenue of $73.4 million, an increase of 50% compared to revenue of $48.8 million for the same period of fiscal 2015. First quarter fi...